Baxion
ScreeningTagsAlerts

Drugs Made In America Acquisition II Corporation.

DMII·NASDAQ·$10.07Share Price as of 11/2·$529MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/2610-QQ1 ended 03/31/2605/14/2610-KFY 202504/15/2610-QQ3 ended 09/30/2511/18/25

Disclosures

8-KCurrent report04/28/268-KCurrent report04/03/268-KCurrent report03/17/268-KCurrent report03/06/268-KCurrent report03/06/26

Prospectuses and Registrations

424B4Prospectus09/25/25S-1/ARegistration statement (amended)09/16/25S-1/ARegistration statement (amended)09/15/25S-1/ARegistration statement (amended)09/05/25S-1Registration statement (IPO)07/21/25

Proxies

No matching filings.

Ownership

Form 4Insider transaction10/17/25Form 4Insider transaction10/02/25SC 13DBeneficial ownership10/02/25Form 4Insider transaction10/01/25Form 4Insider transaction10/01/25

Other

NT 10-KLate filing notification (10-K)04/01/26NT 10-QLate filing notification (10-Q)11/17/258-A12B8-A12B09/24/25CERTCEO/CFO certification09/24/25EFFECTRequest for effectiveness09/24/25

Latest Filings

10-QQ2 ended 06/30/2608/14/2610-QQ1 ended 03/31/2605/14/268-KCurrent report04/28/2610-KFY 202504/15/268-KCurrent report04/03/26

Ownership

Form 4Insider transaction10/17/25Form 4Insider transaction10/02/25SC 13DBeneficial ownership10/02/25Form 4Insider transaction10/01/25Form 4Insider transaction10/01/25
  • Baxion © 2026
  • Terms
  • Privacy
  • Contact